MedTrace Logo

Cardiopulmonary Effects of Prone Position in CARDS

NCT06456606 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2024-06-13

No results posted yet for this study

Summary

In coronavirus disease-2019 (COVID-19)-related ARDS (C-ARDS), especially in the severe form, increased shunt rate, impaired ventilation/perfusion ratio (V/Q), hypoxic pulmonary vasoconstriction inhibition, and increased immune microthrombosis may have similar effects on the right ventricle .The cardiopulmonary pathophysiology and outcomes of C-ARDS vary, and this variability requires monitoring to follow the diagnosis and treatment process. This study aimed to increase the treatment success of the prone position in C-ARDS and to provide a prognostic factor for survival by analyzing and monitoring heart-lung interactions. Therefore, we used transesophageal echocardiography (TEE) to evaluate the cardiopulmonary effects of prone position.

Conditions

  • ARDS Due to Disease Caused by SARS Co-V-2
  • Right Ventricular Dysfunction

Interventions

PROCEDURE

before prone position

It was evaluated with transesophageal echocardiography

PROCEDURE

the first hour of prone position

It was evaluated with transesophageal echocardiography

PROCEDURE

the first hour of returning to the supine position

It was evaluated with transesophageal echocardiography

Sponsors & Collaborators

  • Bakirkoy Dr. Sadi Konuk Research and Training Hospital

    lead OTHER_GOV

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-01
Primary Completion
2022-04-10
Completion
2022-05-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06456606 on ClinicalTrials.gov